Nancy Messier

Nancy Messier is the current Vice President of Drug Discovery at Feldan Therapeutics. Nancy has also previously worked with Feldan Therapeutics, Génétique humaine, SFA, and Université Laval. Nancy's work history is mostly in research, involving construction and infection of viruses and cells for gene therapy, as well as cell population analysis and purification. Nancy has also taught courses in various departments at Université Laval.

A direct report to Nancy Messier is and Vanessa Théberge - Project Manager, Drug Discovery. Their manager is François-Thomas Michaud, Board Member & CEO. Nancy Messier works with Anna Xue Cheng - Director R&D, Pulmonary Drug Delivery, Vincent Ménard - VP, Finance & Business Development, and David Guay - VP, Innovation & Technology.